Association of Nurse Practitioners in Business Alabama Chapter

16 Hours Pharmacology CME for Clinical Nurse Practitioners - Recorded Live for the Veterans Administration

CE Information
16.0 CE credits (16.0 pharmacology)
Completion Time
16 hours
Available Until
August 28, 2027
Posted By
University Learning Systems
University Learning Systems University Learning Systems
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.

Overview

Specialties
Acute Care, Adult, Family, and Gerontological
Subspecialties
Cardiovascular, Emergency, Gastroenterology, and Primary Care
Clinical Topics
Alzheimer's, Cardiovascular Disease, Depression, Diabetes, IBD, Inflammatory Bowel Disease, Kidney Disease, Migraine, New Drugs, Pharmacology, Primary Care, Urology, and Women's Health

The content of theses courses were developed specifically for the needs of NPs at the VA via a needs assessment.
The courses are taught by clinical pharmacy school faculty who see patients daily.
Now in its third year the course has received outstanding reviews from attendees.
This is a great way to see why students have been attending ULS seminars for since 1979.
ULS specializes in live pharmacology CME.

Kudos By Topic

  1. "amazing presentation! loved the case based approach and interaction with the learners. fantastic!"
  2. "excellent speaker w respect to updated and complicated pharmacology! great presentation"
  3. "Fantastic information they were met and she did a good job presenting a dry subject"
  4. "This was a great presentation! Loved the interactive content."
  5. Great information- presenter very passionate
  6. I learnt a lot of current and new information. Thank you
  7. Use of case studies great tool to enhance learning.Presenter was fantastic.
  8. Even at the end of two long days I had no problem paying attention and keeping engaged.

Learning Objectives

Topic 1: GI Pharmacology Update - Dr. Buch - 4 Hours

Assessing Abdominal Pain: A Practical Review:

  • Define the appropriate workup for several interactive cases of acute abdominal pain.

  • Illustrate the pitfalls in making a diagnosis.

Clinical Dilemmas in GI Bleeding:

  • Describe the limitations of colonoscopy.

  • Recognize the importance of “Alarm Symptoms”.

  • Describe advanced endoscopic techniques that are used to evaluate GI bleeding.

  • Recognize the safe use of anti-platelet and anticoagulation medications post GI bleeding.

Colon Cancer Evaluation and Prevention: What’s New?

  • State the best practices that lead to colon cancer prevention.

  • Review types of polyps and their consequences.

  • Review the pitfalls of colonoscopy screening.

  • .Show reasonable alternatives to colonoscopy.

Peptic Ulcer Disease and Helicobacter Highlights:

  • Identify the importance of risk factors in the development of UGI bleeding.

  • Select appropriate candidates for long term PPI therapy.

  • Review noninvasive ways of making a H pylori diagnosis.

  • Manage antibiotic therapy for Helicobacter 2024.

Topic 2: An Evidence-Based Approach to Treating T2D in Adults - Dr. Weart - 2 Hours

  • Describe the 2024 American Diabetes Association Standards of Care for Patients with Diabetes and the evidence on which they are based.

  • Apply the results of landmark diabetes trials that established improved glycemic control reduces the risk of diabetes-related complications in patients with T2D

  • Apply the evolving paradigm by which the treatment of T2D (A1C reduction) has shifted to an outcome-based approach focused on risk reduction, particularly in older patients with established CVD, HF, CKD and/or Obesity.

Topic 3: Chronic Kidney Disease Pharmacotherapy - Dr. Vondracek - 2 Hours

  • Discuss the mechanisms of action, role and pros/cons of SGLT2-inhibitors, GLP-1 inhibitors and finerenone in the prevention of CKD progression.

  • Describe the mechanisms of action, role and pros/cons of therapies for the management of hyperkalemia in patients with CKD.

  • Choose appropriate therapy for the management of hyperkalemia in a patient with CKD.

  • Describe the mechanisms of action, role, and pros/cons of therapies for the management of anemia in patients with CKD.

  • Initiate appropriate iron and ESA therapy in a patient with anemia and CKD.

  • Discuss the roles of phosphate, calcium, vitamin D and parathyroid hormone in the development of Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD)

  • Describe the mechanisms of action, and pros/cons of therapies for the management of CKD-MBD.

  • Choose an appropriate therapy for the management of hyperphosphatemia, low vitamin D and secondary hyperparathyroidism in a patient with CKD. 

Topic 4: Treatment of Alzheimer’s, Depression and Adult Onset ADHD/ADD - Dr. Caballero-2 Hours

Alzheimer’s Disease and Depression Treatment

  • Explain standard and newer treatment options for cognitive disorders (e.g., Alzheimer’s disease).

  • Recognize preferred treatments for managing comorbid psychiatric issues in patients with cognitive disorders.

  • Describe how to counsel caregivers and patients regarding treatment options for cognitive disorders.

ADHD

  • Identify differences between stimulant medications and formulations.

  • Discuss the utility of using non-stimulants in the treatment of adult ADHD.

  • Describe comorbidities that may impact treatment in adult ADH.

Topic 5: AHA/ACC/HFSA Guidelines for the Management of Heart Failure, Lipids, and Blood Pressure - Dr. Saseen-2 Hours

  • Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension, hypercholesterolemia, and heart failure.

  • Identify the optimal use of combination therapy pharmacotherapy for patients with hypertension, including resistant hypertension.

  • Describe the similarities and differences in pharmacotherapy for heart failure with reduced ejection fraction and heart failure with preserved ejection fraction.

  • List recommendations from the ACC Expert Consensus Decision Pathway for nons-statins and treatment of hypertriglyceridemia.

  • Discuss new and emerging pharmacotherapy options for patients with dyslipidemia.

  • Select treatment plans to treat patients with hypertension, heart failure, and/or dyslipidemia.

Topic 6: Treatment of Anaphylaxis – in Primary Care and Acute Care and Seizures in Acute Care - Dr. Sikora-1 Hour

  • Review treatment approach for anaphylaxis.

  • Create a treatment plan for the acute management of seizures.

  • Identify common adverse effects from common anti-epileptic medications.

Topic 7: Anti-infective Treatment (with Beers criteria) for Urinary Tract Infections (UTIs), Sinusitis, Pneumonia and Cellulitis-Dr. Bland-2 Hours

  • Evaluate methods to improve safety of antimicrobial prescribing in the elderly

  • Review antimicrobial therapy recommendations within Beers Criteria

  • Examine best antimicrobials practices through case application

Topic 8: Pharmacotherapy for Migraine Headaches including Botox for Headaches and TMJ - Dr. Bland-1 Hour

  • Review current older management strategies for migraine headaches.

  • Discuss role of newer agents including botulinum toxin.

  • Examine best practices through case application.

Speakers

Peter Buch
Peter Buch MD, AGAF, FACP

An accomplished medical educator and professional speaker on Gastroenterology

Peter Buch, MD, AGAF, FACP, is a double board-certified clinical gastroenterologist, currently leading a team that treats all GI conditions. Dr. Buch sits on editorial boards for numerous professional journals and is a highly sought-after international presenter. Dr. Buch has a passion for teaching. His style is case-based, practical, very interactive and evidence supported. Dr. Buch’s expertise has been shared with experienced clinicians and advanced-level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.

Christopher Bland
Christopher Bland Pharm.D., FCCP, FIDSA, BCPS

Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS
Clinical Professor, Clinical and Administrative Pharmacy,

Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS Clinical Professor, Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Clinical Pharma- cy Specialist, St. Joseph’s/ Candler Health System, Sa- vannah, Georgia. Co-founder of SERGE-45, practice-based research network, co-founder of TeachMePharm, drug therapy teaching platform.

Dr. Joshua Caballero
Dr. Joshua Caballero PharmD, BCPP, FCCP

Dr. JOSHUA CABALLERO, Pharm.D., BCPP, FCCP
Clinical and Administrative Pharmacy, Athens
Associate Professor Clinical and Administrative Pharmacys
University of Georgia, Athens, GA 30602

He received his undergraduate degree in Psychology from the University of Florida and his PharmD from the University of Tennessee Health Science Center in Memphis. During his postdoctoral training, he completed a PGY2 in Psychiatry at the University of Texas Health Science Center in San Antonio and a Pharmacotherapy Fellowship at The Ohio State University

Dr. Sheryl (Follin) Vondracek
Dr. Sheryl (Follin) Vondracek Pharm.D., FCCP, BCPS

Board Certified Pharmacotherapy Specialist, Associate Professor, Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado

Dr. C. Wayne Weart
Dr. C. Wayne Weart Pharm.D., BCPS, FASHP

Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP Professor Emeritus of Family Medicine, Department of Family Medicine, Medical University of South Carolina, Professor Emeritus of Clinical Pharmacy & Outcome Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.

Dr. Andrea Sikora
Dr. Andrea Sikora Pharm.D., MSCR, FCCM, BCCCP

Clinical Associate Professor University of Georgia, College of Pharmacy Clinical And Administrative Pharmacy, Augusta GA

CE Information

This activity offers 16.0 CE credits (16.0 pharmacology) to attendees.

Accredited by ACPE, AAFP, ANCC, AMA PRA Category 1 Credit™..

Accreditation

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

  • As an ACPE accredited provider, University Learning Systems is able to report credit directly to CPE Monitor. Credit for pharmacists is reported automatically to CPE-Monitor upon completion of the course. NO statement of credit is provided.

  • All other professions will receive a statement of credit upon completion of the course.

  • ACPE Credit is accepted by nurse practitioner certification organizations for pharmacology and general CE credit.

  • University Learning Systems is approved by the California Board of Registered Nursing and is a CE Broker approved provider for pharmacy, nursing and medicine.

  • This course provides Category 2 credit for physicians and physician assistants.

  • Credit to CE Broker is reported manually at this time. Please provide your state license number if you need credit reported to CE Broker.

  • These courses were recorded August 28-29, 2024 and are valid for credit until August 28, 2027.

Disclosures

No Disclosures


Ready to start this activity?

Login required. You will be redirected to an external website to register for and complete this activity.

Log in and start activity